AGER and metabolic disease: Although the results of previous studies supported that gut microbiota has an effect on the AGE-RAGE pathway, it has not been demonstrated whether astragaloside IV-PESV can regulate the AGE-RAGE pathway to inhibit PCa tumor growth by improving gut microbiota and metabolic disorders.